Däniken, Switzerland

Marianne Huerzeler

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Allocyte Pharmaceuticals Ag. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Huerzeler. Retrieved from https://idiyas.com/inventor/marianne-huerzeler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Marianne Huerzeler

Introduction

Marianne Huerzeler is a notable inventor based in Daniken, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule inhibitors.

Latest Patents

Marianne holds 1 patent for her invention titled "Small molecule LFA-1 inhibitors." This patent relates to novel compounds that inhibit the interaction of LFA-1 with its counter ligands, showcasing her innovative approach to addressing medical challenges.

Career Highlights

Marianne is currently associated with Allocyte Pharmaceuticals AG, where she continues to advance her research and development efforts. Her work is pivotal in the pharmaceutical industry, contributing to the creation of effective therapeutic solutions.

Collaborations

Some of her notable coworkers include Werner Breitenstein and Terence Alfred Kelly, who collaborate with her on various projects within the company.

Conclusion

Marianne Huerzeler's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a key figure in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…